No Data
No Data
Piper Sandler Maintains ALX Oncology(ALXO.US) With Buy Rating, Maintains Target Price $21
Piper Sandler analyst Christopher Raymond maintains $ALX Oncology(ALXO.US)$ with a buy rating, and maintains the target price at $21.According to TipRanks data, the analyst has a success rate of 51.3%
ALX Oncology(ALXO.US) Officer Sells US$10,025.22 in Common Stock
$ALX Oncology(ALXO.US)$ Officer Pinto Shelly sold 1,823 shares of common stock on Jul 5, 2024 at an average price of $5.4993 for a total value of $10,025.22.Source: Announcement What is statement of
ALX Oncology(ALXO.US) Officer Sells US$19,044.93 in Common Stock
$ALX Oncology(ALXO.US)$ Officer Randolph Sophia sold 3,273 shares of common stock on Jul 1, 2024 at an average price of $5.8188 for a total value of $19,044.93.Source: Announcement What is statement o
ALX Oncology(ALXO.US) Officer Sells US$7,989.21 in Common Stock
$ALX Oncology(ALXO.US)$ Officer Pinto Shelly sold 1,373 shares of common stock on Jul 1, 2024 at an average price of $5.8188 for a total value of $7,989.21.Source: Announcement What is statement of ch
ALX Oncology(ALXO.US) Officer Sells US$62,598.65 in Common Stock
$ALX Oncology(ALXO.US)$ Officer Pons Jaume sold 10,758 shares of common stock on Jul 1, 2024 at an average price of $5.8188 for a total value of $62,598.65.Source: Announcement What is statement of ch
Merck's (MRK) New Pneumococcal Jab Capvaxive Gets CDC Panel Vote
The Real Wojak : Do you have like a top 3-5 that you like more than all the other ones? This list is way too long
72991267 : Glad I have some $Candel Therapeutics (CADL.US)$ after my disastrous SBFM.
Rana Hasan1 : List too long